Dean Investment Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-40,698
Closed -$3.05M 213
2016
Q1
$3.05M Sell
40,698
-135
-0.3% -$10.2K 0.62% 78
2015
Q4
$3.14M Sell
40,833
-535
-1% -$40.3K 0.69% 62
2015
Q3
$2.77M Buy
41,368
+468
+1% +$34.5K 0.62% 74
2015
Q2
$3.03M Sell
40,900
-135
-0.3% -$10.3K 0.69% 50
2015
Q1
$3.2M Sell
41,035
-194
-0.5% -$14.7K 0.74% 52
2014
Q4
$2.98M Sell
41,229
-34,070
-45% -$2.37M 0.69% 57
2014
Q3
$4.67M Buy
75,299
+297
+0.4% +$18.9K 1.13% 26
2014
Q2
$4.78M Sell
75,002
-1,049
-1% -$63.7K 1.1% 25
2014
Q1
$4.68M Sell
76,051
-107
-0.1% -$6.23K 1.13% 24
2013
Q4
$4.37M Sell
76,158
-351
-0.5% -$19.9K 1.05% 26
2013
Q3
$4.07M Sell
76,509
-981
-1% -$52.8K 1.07% 27
2013
Q2
$3.99M Buy
+77,490
New +$3.83M 1.14% 26

Other funds holding MDT

Dean Investment Associates's MDT Position: Q2 2016 in Review

Dean Investment Associates sold out of Medtronic (MDT) in Q2 2016, closing a stake of 40,698 shares — an estimated $3.05M sold.

Dean Investment Associates first reported a position in MDT in Q2 2013 and held it in 12 quarters. The position peaked at $4.78M in Q2 2014. 1,262 funds tracked by Wall St. Rank hold MDT as of Q2 2016.

  • Dean Investment Associates reported no remaining Medtronic position as of Q2 2016 after selling out during the quarter.
  • Dean Investment Associates sold 40,698 Medtronic shares in Q2 2016, an estimated $3.05M.
  • Dean Investment Associates first reported a position in Medtronic in Q2 2013 and held it in 12 quarters.
  • Dean Investment Associates's Medtronic position peaked at $4.78M in Q2 2014.
  • 1,262 funds tracked by Wall St. Rank held Medtronic as of Q2 2016.

Based on Dean Investment Associates's 13F filing for Q2 2016, filed 3 Aug 2016.